Core Viewpoint - The regulatory framework of the US and China capital markets is continuously adjusting, creating both opportunities and challenges for Chinese companies seeking cross-border financing. The increasing entry barriers for traditional IPOs and the evolving SPAC landscape are pushing smaller enterprises towards the OTC market as a pragmatic entry point into international capital markets [1]. Group 1: Direct IPO (NYSE/NASDAQ) - The traditional IPO route offers significant advantages such as large fundraising potential (with a proposed minimum of $25 million), strong liquidity, and notable brand endorsement, making it suitable for mature tech or manufacturing firms [2]. - However, the disadvantages are considerable, including a lengthy SEC review process of 12-24 months, underwriting fees of 7%-10% of the raised amount, and stringent financial criteria, particularly with the anticipated increase in market capitalization requirements by NASDAQ [2]. - Post-2025, while the resumption of filing windows is expected, compliance issues related to VIE structures and data security reviews remain significant obstacles [2]. Group 2: SPAC Merger Listing - The SPAC model allows for rapid listing through a "shell company fundraising - merger injection" approach, reducing the timeline to 6-9 months and imposing no strict profitability requirements [3]. - Nonetheless, with tightening regulations expected in 2025, SPACs face challenges such as high redemption rates (averaging over 97%) and rising PIPE financing costs (5%-7% of the raised amount), making it more suitable for companies in AI and renewable energy sectors that can effectively communicate their value [3]. Group 3: OTC Market Listing - The OTC market represents the lowest entry barrier, characterized by its "stepping stone" attribute, making it an optimal choice for small and medium-sized enterprises [4]. - For example, the OTCQB listing process typically spans 6-9 months, involving foundational setup (2-3 weeks), issuance and listing (3-6 weeks), requiring 50-100 shareholders and a minimum share price of $1 [5]. - Companies can transition to NASDAQ by meeting specific criteria, such as net assets of at least $5 million or a two-year cumulative net profit of $750,000 alongside net assets of $4 million, with additional requirements including 1 million shares in circulation and a share price of at least $4 [6]. Group 4: Compliance Preparation - The compliance preparation phase for OTC listing takes approximately 4-5 weeks, involving DTC custody applications and drafting the S-1 prospectus [7]. - Following this, the SEC review process lasts about 4 weeks, during which the application is submitted, inquiries are addressed, and a stock code is obtained [7].

Core Viewpoint - The article discusses the opportunities and risks associated with reverse mergers in the U.S. stock market, emphasizing the strict regulations imposed by the SEC since 2020 and outlining the necessary steps for a successful reverse merger [2][4]. Group 1: Core Process of Reverse Mergers - The core process of reverse mergers includes selecting a compliant shell type, conducting due diligence, signing a reverse merger agreement, submitting SEC Form 8-K, and applying for a main board upgrade [2][3][4]. - Different types of shell companies include blank check companies, OTC shell companies, and SPACs, each with distinct characteristics and suitability [2][3]. Group 2: Key Operational Steps - The first step involves due diligence to confirm the shell company has no debts or lawsuits [3]. - The second step is to execute a reverse merger agreement, followed by the submission of Form 8-K to the SEC within 15 days after the acquisition [4]. - To list on NASDAQ or NYSE, companies must meet specific conditions, including a net asset of at least $5 million and a stock price of at least $4 [4]. Group 3: Core Risks of Reverse Mergers - New SEC regulations require shell companies to submit Form 10 immediately after listing, reducing the previous one-year grace period [5]. - The lock-up period for original shell shareholders has been extended from 6 months to 12 months under Rule 144 [5]. - There is a high risk of fraud, particularly in the OTC market, where approximately 40% of OTC shells have undisclosed related-party transactions or inflated assets [5][6]. Group 4: SPAC as a Mainstream Alternative - SPACs have become a mainstream method for reverse mergers, with a success rate exceeding 80% [7]. - The cost comparison between traditional reverse mergers and SPACs shows that SPACs involve hidden costs such as 20% equity incentives for sponsors [7]. - The operational flow of SPACs includes an IPO, target search within 24 months, and subsequent De-SPAC merger [7]. Group 5: Compliance Path Recommendations - Traditional reverse mergers are suitable for small businesses with annual revenues of less than $5 million, while SPAC mergers are recommended for medium to large enterprises [9][10]. - Key steps for SPAC mergers include selecting reputable SPAC sponsors, negotiating De-SPAC valuations, and signing PIPE financing agreements [9][10]. - Direct IPOs are highlighted as having the lowest regulatory risk and high brand premium, with a timeline of 6-9 months for completion [10][12].